SPOTLIGHT -
Neoadjuvant Therapy As a Platform for Drug Development: Current Controversies and Regulatory Perspectives
This commentary addresses our perspectives from a regulatory standpoint, as well as some controversies related to the use of neoadjuvant therapy as a platform for drug development.